Real-time enrollment status for this sars cov-2 post-acute sequelae clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 3:03 PM UTC
| NCT Number | NCT07781501 |
| Recruiting Status | Recruiting |
| Condition | SARS CoV-2 Post-Acute Sequelae |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of North Carolina, Chapel Hill |
| Last Updated on CT.gov | August 24, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT07781501 is currently recruiting participants. This clinical trial study for sars cov-2 post-acute sequelae is actively seeking new participants at 1 location across the United States. The study is sponsored by University of North Carolina, Chapel Hill. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07781501 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07781501 was last updated 1 week ago (August 24, 2026). HelloStudys verifies this status automatically.